Steven Gillis is Director of Codiak BioSciences, Inc.. Currently has a direct ownership of 8,750 shares of CDAK, which is worth approximately $87. The most recent transaction as insider was on Feb 16, 2023, when has been sold 8,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.75K
0% 3M change
0% 12M change
Total Value Held $87

STEVEN GILLIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
8,750 Added 50.0%
8,750 Common Stock

Also insider at

VBIV
VBI Vaccines Inc Healthcare
FIXX
Homology Medicines, Inc. Healthcare
SG

Steven Gillis

Director
Chicago, IL

Track Institutional and Insider Activities on CDAK

Follow Codiak BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDAK shares.

Notify only if

Insider Trading

Get notified when an Codiak Bio Sciences, Inc. insider buys or sells CDAK shares.

Notify only if

News

Receive news related to Codiak BioSciences, Inc.

Track Activities on CDAK